Bank of New York Mellon’s Bristol-Myers Squibb BMY Stock Holding History

Bank of New York Mellon’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26B	Sell	21,821,384 -1,479,953	-6%	-$85M	0.21%	86
2026 Q1	$1.41B	Sell	23,301,337 -1,194,538	-5%	-$69.6M	0.26%	69
2025 Q4	$1.32B	Buy	24,495,875 +7,837,485	+47%	+$377M	0.23%	76
2025 Q3	$751M	Sell	16,658,390 -4,202,979	-20%	-$196M	0.13%	137
2025 Q2	$966M	Sell	20,861,369 -6,003,704	-22%	-$295M	0.18%	105
2025 Q1	$1.64B	Buy	26,865,073 +2,131,205	+9%	+$124M	0.32%	57
2024 Q4	$1.4B	Buy	24,733,868 +1,482,410	+6%	+$82.8M	0.26%	71
2024 Q3	$1.2B	Buy	23,251,458 +7,050,918	+44%	+$331M	0.22%	90
2024 Q2	$673M	Sell	16,200,540 -506,033	-3%	-$22.6M	0.13%	147
2024 Q1	$906M	Sell	16,706,573 -315,737	-2%	-$16.1M	0.17%	110
2023 Q4	$873M	Sell	17,022,310 -91,720	-0.5%	-$4.81M	0.18%	112
2023 Q3	$993M	Sell	17,114,030 -42,783	-0.2%	-$2.62M	0.22%	91
2023 Q2	$1.1B	Sell	17,156,813 -722,629	-4%	-$48.5M	0.23%	87
2023 Q1	$1.24B	Sell	17,879,442 -712,469	-4%	-$50.3M	0.27%	76
2022 Q4	$1.34B	Sell	18,591,911 -354,464	-2%	-$26.7M	0.31%	64
2022 Q3	$1.35B	Sell	18,946,375 -254,022	-1%	-$18.4M	0.33%	58
2022 Q2	$1.48B	Sell	19,200,397 -340,232	-2%	-$25.9M	0.34%	57
2022 Q1	$1.43B	Sell	19,540,629 -738,751	-4%	-$49.6M	0.28%	77
2021 Q4	$1.26B	Sell	20,279,380 -2,429,075	-11%	-$142M	0.23%	87
2021 Q3	$1.34B	Sell	22,708,455 -429,136	-2%	-$28.3M	0.26%	74
2021 Q2	$1.55B	Buy	23,137,591 +672,723	+3%	+$43.9M	0.3%	66
2021 Q1	$1.42B	Sell	22,464,868 -4,158,544	-16%	-$259M	0.29%	70
2020 Q4	$1.65B	Sell	26,623,412 -1,281,120	-5%	-$78.8M	0.36%	58
2020 Q3	$1.68B	Buy	27,904,532 +644,814	+2%	+$38.8M	0.42%	47
2020 Q2	$1.6B	Buy	27,259,718 +2,369,939	+10%	+$142M	0.43%	45
2020 Q1	$1.39B	Buy	24,889,779 +781,996	+3%	+$47.8M	0.46%	44
2019 Q4	$1.55B	Buy	24,107,783 +7,317,255	+44%	+$419M	0.4%	47
2019 Q3	$851M	Sell	16,790,528 -672,218	-4%	-$31.6M	0.23%	87
2019 Q2	$792M	Sell	17,462,746 -691,423	-4%	-$32.2M	0.22%	91
2019 Q1	$866M	Buy	18,154,169 +850,285	+5%	+$42.4M	0.24%	81
2018 Q4	$899M	Buy	17,303,884 +180,711	+1%	+$9.71M	0.28%	71
2018 Q3	$1.06B	Buy	17,123,173 +277,927	+2%	+$16.5M	0.27%	71
2018 Q2	$932M	Sell	16,845,246 -1,550,006	-8%	-$83.7M	0.25%	74
2018 Q1	$1.16B	Sell	18,395,252 -323,818	-2%	-$20.8M	0.32%	61
2017 Q4	$1.15B	Sell	18,719,070 -136,343	-0.7%	-$8.53M	0.3%	67
2017 Q3	$1.2B	Buy	18,855,413 +1,335,290	+8%	+$78M	0.33%	65
2017 Q2	$976M	Sell	17,520,123 -910,985	-5%	-$49.6M	0.28%	71
2017 Q1	$1B	Sell	18,431,108 -223,524	-1%	-$12.3M	0.28%	71
2016 Q4	$1.09B	Buy	18,654,632 +132,108	+0.7%	+$7.22M	0.31%	66
2016 Q3	$999M	Sell	18,522,524 -2,637,225	-12%	-$169M	0.3%	68
2016 Q2	$1.56B	Sell	21,159,749 -182,247	-0.9%	-$12.9M	0.48%	39
2016 Q1	$1.36B	Sell	21,341,996 -775,942	-4%	-$48.9M	0.41%	49
2015 Q4	$1.52B	Sell	22,117,938 -826,480	-4%	-$54.6M	0.46%	42
2015 Q3	$1.36B	Sell	22,944,418 -304,037	-1%	-$19.3M	0.42%	47
2015 Q2	$1.55B	Sell	23,248,455 -1,178,241	-5%	-$77.6M	0.43%	46
2015 Q1	$1.58B	Sell	24,426,696 -65,348	-0.3%	-$4.09M	0.41%	48
2014 Q4	$1.45B	Sell	24,492,044 -91,526	-0.4%	-$5.16M	0.38%	52
2014 Q3	$1.26B	Sell	24,583,570 -1,055,894	-4%	-$52.7M	0.34%	58
2014 Q2	$1.24B	Sell	25,639,464 -776,674	-3%	-$38.3M	0.33%	55
2014 Q1	$1.37B	Buy	26,416,138 +867,960	+3%	+$46.2M	0.37%	49
2013 Q4	$1.36B	Sell	25,548,178 -3,820,845	-13%	-$195M	0.38%	48
2013 Q3	$1.36B	Buy	29,369,023 +3,046,446	+12%	+$134M	0.4%	46
2013 Q2	$1.18B	Buy	+26,322,577	New	+$1.14B	0.37%	49

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon's BMY Position: Q2 2026 in Review

Bank of New York Mellon reduced its Bristol-Myers Squibb (BMY) stake by 6.4% in Q2 2026, selling an estimated $85M and leaving 21,821,384 shares worth $1.26B. The position accounts for 0.21% of the portfolio, ranked #86.

Bank of New York Mellon first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.68B in Q3 2020. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bank of New York Mellon held 21,821,384 shares of Bristol-Myers Squibb worth $1.26B as of Q2 2026.
Bank of New York Mellon sold 1,479,953 Bristol-Myers Squibb shares in Q2 2026, an estimated $85M.
Bristol-Myers Squibb made up 0.21% of Bank of New York Mellon's portfolio in Q2 2026, its #86 holding.
Bank of New York Mellon first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Bank of New York Mellon's Bristol-Myers Squibb position peaked at $1.68B in Q3 2020.
2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.